Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Bone marrow failure happens when your bone marrow is unable keep up with your body's need for healthy blood cells. Bone marrow is the soft, spongy center of our bones. It produces all blood cells: red blood cells, white blood cells and platelets. Red
blood cells contain the protein hemoglobin that carries oxygen from the lungs to tissues. White blood cells fight infection. Platelets are important for blood to clot.
There are many types of bone marrow failure, including:
In about 30% of bone marrow failure cases, a specific diagnosis has not been identified.
The Bone Marrow Failure and Myelodysplastic Syndrome (MDS) Program at
Dana-Farber/Boston Children's Cancer and Blood Disorders Center is recognized as one of the nation’s best pediatric treatment and research programs for bone marrow failure, MDS, and related conditions. Our patients have access to advanced diagnostic
evaluations and treatments, including individually tailored stem cell transplantation and ongoing
clinical trials that are investigating new treatments
Learn more about the Bone Marrow Failure and MDS Program.
New Patient Appointments
Clinical Trials Questions?